World's Best Scientists 2026 revealed!
Award Badge
Medicine
Korea
2026

D-Index & Metrics

Medicine

D-Index
118
Citations
87039
World Ranking
3964
National Ranking
5

Research.com Recognitions

  • 2026 - Research.com Medicine in Korea Leader Award
  • 2025 - Research.com Medicine in Korea Leader Award
  • 2023 - Research.com Medicine in Korea Leader Award
  • 2022 - Research.com Medicine in Korea Leader Award

Overview

Dong-Wan Kim is affiliated with Seoul National University Hospital in South Korea and has a primary research focus on engineering, with a specialization in electrical and electronic engineering. Their scholarly work spans various subfields including renewable energy, sustainability and the environment, materials chemistry, electronic, optical and magnetic materials, and automotive engineering.

Their research emphasizes advanced battery materials and technologies, a topic they have extensively contributed to through numerous publications. Core themes in their work include advancements in battery materials, advanced battery technologies research, electrocatalysts for energy conversion, supercapacitor materials and fabrication, and fuel cells and related materials.

Key papers authored or co-authored by Dong-Wan Kim cover a range of topics and years, including:

  • Repeated-oral dose toxicity of polyethylene microplastics and the possible implications on reproduction and development of the next generation (2020, Toxicology Letters)
  • Highly Efficient Perovskite-Based Electrocatalysts for Water Oxidation in Acidic Environments: A Mini Review (2020, Advanced Energy Materials)
  • Porous Lithiophilic Li-Si Alloy-Type Interfacial Framework via Self-Discharge Mechanism for Stable Lithium Metal Anode with Superior Rate (2021, Advanced Energy Materials)
  • Peroxymonosulfate activation by carbon-encapsulated metal nanoparticles: Switching the primary reaction route and increasing chemical stability (2020, Applied Catalysis B: Environmental)
  • Synergistic Design of Multifunctional Interfacial Zn Host toward Practical Zn Metal Batteries (2022, Advanced Energy Materials)

Dong-Wan Kim has frequently published in several scientific journals, with the highest number of publications appearing in:

  • Advanced Energy Materials (15 publications)
  • International Journal of Energy Research (14 publications)
  • Chemical Engineering Journal (13 publications)
  • Journal of Materials Chemistry A (6 publications)
  • Applied Catalysis B: Environmental (5 publications)

The scientist has collaborated regularly with a group of co-authors, including:

  • Gwang-Hee Lee (27 co-authored works)
  • Changhoon Choi (22 co-authored works)
  • Hyunseok Yoon (15 co-authored works)
  • Myeong-Chang Sung (15 co-authored works)
  • Hee Jo Song (14 co-authored works)

Best Publications

  • Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

    Roy S. Herbst;Paul Baas;Dong Wan Kim;Enriqueta Felip

  • Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Kazuhiko Nakagawa;Takashi Seto

  • First-line crizotinib versus chemotherapy in ALK-positive lung cancer

    Benjamin J. Solomon;Tony Shu-kam Mok;Dong Wan Kim;Yi Long Wu

  • Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

    Solange Peters;D. Ross Camidge;Alice T. Shaw;Shirish Gadgeel

  • AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

    Pasi A. Jänne;James Chih-Hsin Yang;Dong Wan Kim;David Planchard

  • Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes

    Ki Tae Nam;Dong Wan Kim;Pil J. Yoo;Chung Yi Chiang

  • AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

    Darren A.E. Cross;Susan E. Ashton;Serban Ghiorghiu;Cath Eberlein

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Ranee Mehra;Daniel S W Tan

  • Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

    D. Ross Camidge;Yung Jue Bang;Eunice L. Kwak;A. John Iafrate

  • Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

    Keunchil Park;Eng Huat Tan;Ken O'Byrne;Li Zhang

  • Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

    Sae-Won Han;Tae-You Kim;Pil Gyu Hwang;Soohyun Jeong

  • Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.

    Tae You Kim;Dong-Wan Kim;Jae-Yong Chung;Sang Goo Shin

  • First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Todd M. Bauer;Filippo de Marinis;Enriqueta Felip

  • Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

    Sai Hong Ignatius Ou;Jin Seok Ahn;Luigi De Petris;Ramaswamy Govindan

  • Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

    June Chul Lee;Kyung Mi Lee;Dong Wan Kim;Dae Seog Heo

  • Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.

    Peter Ballard;James W.T. Yates;Zhenfan Yang;Dong-Wan Kim

  • Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

    Dong-Wan Kim;Dong-Wan Kim;Marcello Tiseo;Myung-Ju Ahn;Karen L Reckamp

  • Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.

    Sai Hong Ignatius Ou;Eunice L. Kwak;Christina Siwak-Tapp;Joni Dy

  • Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.

    James Chih Hsin Yang;Myung Ju Ahn;Dong Wan Kim;Suresh S. Ramalingam

Frequent Co-Authors

Dae Seog Heo
Dae Seog Heo Seoul National University Hospital
Se-Hoon Lee
Se-Hoon Lee Sungkyunkwan University
Yung-Jue Bang
Yung-Jue Bang Seoul National University
Myung-Ju Ahn
Myung-Ju Ahn Sungkyunkwan University
Seock-Ah Im
Seock-Ah Im Seoul National University Hospital
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Alice T. Shaw
Alice T. Shaw Harvard University
Doo Hyun Chung
Doo Hyun Chung Seoul National University
Yoon Kyung Jeon
Yoon Kyung Jeon Seoul National University Hospital
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is just one of many pathways within healthcare. If you’re considering a flexible or alternative route to a medical career, several fully online degrees can help you build skills and advance in this growing field.

Future leaders in healthcare management may want to explore the cheapest mha online programs, which offer a cost-effective way to gain the credentials needed for administrative roles. Nurses seeking the highest level of clinical practice might consider enrolling in one of the least expensive dnp programs to become nurse practitioners or advanced practice specialists.

If your interest lies in pharmacy, there are now quality pharmd online programs designed for aspiring pharmacists who need scheduling flexibility or live far from an accredited campus. For those who prefer the intersection of technology and healthcare, a bachelor of health information management online opens doors to roles in medical records, data analysis, and healthcare IT.

Each path has unique prerequisites, career outcomes, and admission requirements. These related online degrees can offer new avenues for healthcare impact — even if you don’t take the traditional route through medical school in the USA.

Best Scientists Citing Dong-Wan Kim

Trending Scientists

Recently Published Articles